Kestra Medical Technologies (KMTS) Gains from Investment Securities (2025 - 2026)
Kestra Medical Technologies' (KMTS) quarterly Gains from Investment Securities came in at -$376000.0 in Q2 2026, down 62.07% on a QoQ basis from -$232000.0 in Q1 2026.
Kestra Medical Technologies (KMTS) Gains from Investment Securities (2025 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has 2 years of Gains from Investment Securities data on file, last reported at -$376000.0 in Q2 2026.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$376000.0 in Q2 2026; TTM through Apr 2026 was -$2.7 million, a N/A change from a year earlier, with the FY2026 full-year figure at -$2.7 million, down 200.94% from the prior year.
- Gains from Investment Securities for Q2 2026 stood at -$376000.0, down from -$232000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for KMTS reached as high as $844000.0 in Q4 2025 and fell as low as -$2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Kestra Medical Technologies | 1.23 Bn | 869.98 Mn | 15.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -376,000.00 |
| Apr 30, 2026 | -376,000.00 |
| Jan 31, 2026 | -232,000.00 |
| Jan 31, 2026 | -232,000.00 |
| Oct 31, 2025 | 844,000.00 |
| Oct 31, 2025 | 844,000.00 |
| Jul 31, 2025 | -2.91 Mn |
| Jul 31, 2025 | -2.91 Mn |